Pazdur’s Big Moment: ‘Project Odyssey’ Webinar Gives Oncology Chief External Buy-In On His Ideas To Revamp ODAC

US FDA Oncology Center of Excellence Director Richard Pazdur is not shy about using the bully pulpit to enact the changes he would like to see in cancer drug development. The latest example was a recent webinar as part of OCE’s “Project ODAC Odyssey.”

Pazdur convened the 19 March webinar as part of OCE’s Conversations on Cancer series to discuss topics related to the “past, present and future” of the Oncologic Drugs Advisory Committee, including the use of outside experts, point-counterpoint briefing documents and the importance of taking an up-or-down vote on an application at the end of a meeting